LogoThe NeuroCircuit
About
HackTheNeuron
Recommendations
Subscribe
Upgrade

Brain-Computer Interfaces (BCI)

Linking mind and machine for groundbreaking communication and control.

Neuralink

+5

Weekly Signal: 58 |  Capital Picks the Smaller Footprint

May 24, 2026

•

5 min read

Weekly Signal: 58 | Capital Picks the Smaller Footprint

Meta's NeuralBench lands; NEO goes commercial

Ricardo Albornoz
Ricardo Albornoz

Neurotechnology

+6

Weekly Signal: 57 | Three Strategic Bets Emerge in Neurotech

May 9, 2026

•

2 min read

Weekly Signal: 57 | Three Strategic Bets Emerge in Neurotech

Neuralink, SetPoint, ARIA each bet differently

Ricardo Albornoz
Ricardo Albornoz

Clinical Trial News

+3

Weekly Signal: 55 |  CorTec Enters FDA's TAP for Chronic BCIs

Apr 25, 2026

•

2 min read

Weekly Signal: 55 | CorTec Enters FDA's TAP for Chronic BCIs

Plus €40.6M and a stealth exit

Ricardo Albornoz
Ricardo Albornoz

Neurotechnology

+5

Weekly Signal: 54 | Biohybrid BCI Hits Yale, Cala Clears

Apr 18, 2026

•

2 min read

Weekly Signal: 54 | Biohybrid BCI Hits Yale, Cala Clears

Invasiveness tiers get crowded

Ricardo Albornoz
Ricardo Albornoz

Closed-loop DBS

+5

Weekly Signal: 53 | CorTec Closes the BCI Loop

Apr 11, 2026

•

8 min read

Weekly Signal: 53 | CorTec Closes the BCI Loop

Plus: organoids go to war

Ricardo Albornoz
Ricardo Albornoz

Closed-loop DBS

+6

Weekly Signal: 52 |  The Signal Everyone Used Was Wrong

Apr 4, 2026

•

9 min read

Weekly Signal: 52 | The Signal Everyone Used Was Wrong

Plus: living-neuron BCIs get a surgeon

Ricardo Albornoz
Ricardo Albornoz

Neurotechnology

+5

Weekly Signal: 51 | When the Brain Overcorrects

Mar 28, 2026

•

6 min read

Weekly Signal: 51 | When the Brain Overcorrects

Control, not just signal

Ricardo Albornoz
Ricardo Albornoz

Closed-loop DBS

+5

Weekly Signal: 50 | The Typing Threshold

Mar 21, 2026

•

14 min read

Weekly Signal: 50 | The Typing Threshold

BCIs Close in on Normal Speed

Ricardo Albornoz
Ricardo Albornoz

Ethics & Policy

+6

Weekly Signal: 49 | China Wins the BCI Commercial Race

Mar 14, 2026

•

14 min read

Weekly Signal: 49 | China Wins the BCI Commercial Race

The Regulatory Finish Line Just Moved

Ricardo Albornoz
Ricardo Albornoz

Closed-loop DBS

+5

Weekly Signal: 48 | BCIs Race to First Commercial Products

Mar 8, 2026

•

16 min read

Weekly Signal: 48 | BCIs Race to First Commercial Products

Science Corp. Leads the Pack

Ricardo Albornoz
Ricardo Albornoz

Closed-loop DBS

+7

Weekly Signal: 47 | Adaptive DBS Gets Its Operating Manual

Mar 1, 2026

•

12 min read

Weekly Signal: 47 | Adaptive DBS Gets Its Operating Manual

Plus: Japan's Stem Cell Gamble

Ricardo Albornoz
Ricardo Albornoz

Neuroscience

+5

Weekly Signal: 46 | Forecasting Alzheimer's and Fixing EEG's Data Problem

Feb 21, 2026

•

7 min read

Weekly Signal: 46 | Forecasting Alzheimer's and Fixing EEG's Data Problem

Forecasting the Brain's Future

Ricardo Albornoz
Ricardo Albornoz

Closed-loop DBS

+5

Weekly Signal: 45 | Clinical Signals in Brain Interfaces

Feb 15, 2026

•

6 min read

Weekly Signal: 45 | Clinical Signals in Brain Interfaces

Real-World Decoding Advances

Ricardo Albornoz
Ricardo Albornoz

Neurotechnology

+5

Weekly Signal: 44 | BCI Rehab Evidence Comes Into Focus

Feb 8, 2026

•

7 min read

Weekly Signal: 44 | BCI Rehab Evidence Comes Into Focus

Poststroke outcomes, coverage signals

Ricardo Albornoz
Ricardo Albornoz

Neurotechnology

+6

Weekly Signal: 43 | Durability Replaces Demos in Neurotech

Feb 1, 2026

•

6 min read

Weekly Signal: 43 | Durability Replaces Demos in Neurotech

Long-horizon signals emerge

Ricardo Albornoz
Ricardo Albornoz

Neurotechnology

+4

Weekly Signal: 42 | Neurotech Advances—Military Stakes Rise

Jan 24, 2026

•

6 min read

Weekly Signal: 42 | Neurotech Advances—Military Stakes Rise

Trials, implants, oversight

Ricardo Albornoz
Ricardo Albornoz

Closed-loop DBS

+6

Weekly Signal: 41 | Evidence Tightens Across Neurotechnology

Jan 17, 2026

•

7 min read

Weekly Signal: 41 | Evidence Tightens Across Neurotechnology

Trials, Funding, FDA Signals

Ricardo Albornoz
Ricardo Albornoz

Neurotechnology

+6

Weekly Signal: 40 | The First Signal of 2026

Jan 11, 2026

•

7 min read

Weekly Signal: 40 | The First Signal of 2026

Foundations, funding, and clarity

Ricardo Albornoz
Ricardo Albornoz

Neurotechnology

+6

Weekly Signal: 38 | When BCIs Leave the Lab

Dec 20, 2025

•

6 min read

Weekly Signal: 38 | When BCIs Leave the Lab

Regulation, reality, deployment

Ricardo Albornoz
Ricardo Albornoz

Neurotechnology

+7

Weekly Signal: 37 | Neurotech Moves Home and Wireless

Dec 13, 2025

•

8 min read

Weekly Signal: 37 | Neurotech Moves Home and Wireless

BCIs, Stimulation, and Scale

Ricardo Albornoz
Ricardo Albornoz

Neurotechnology

+6

Weekly Signal: 35 | Ultrasound, BCIs, and the Battle for Brain Data

Nov 29, 2025

•

7 min read

Weekly Signal: 35 | Ultrasound, BCIs, and the Battle for Brain Data

Breakthroughs in Brain Signals and Safety

Ricardo Albornoz
Ricardo Albornoz

Neurotechnology

+4

Weekly Signal: 34 | Speech BCIs, Craving Circuits, and Mental Privacy

Nov 22, 2025

•

6 min read

Weekly Signal: 34 | Speech BCIs, Craving Circuits, and Mental Privacy

Signals shaping neurotech’s future

Ricardo Albornoz
Ricardo Albornoz

Ethics & Policy

+5

Weekly Signal: 33 | Mind Captioning, Neural Barcodes, and Neurotech Ethics

Nov 15, 2025

•

7 min read

Weekly Signal: 33 | Mind Captioning, Neural Barcodes, and Neurotech Ethics

Decoding, biomarkers, and governance

Ricardo Albornoz
Ricardo Albornoz

Neurotechnology

+6

Weekly Signal: 32 | Tiny Implants, Big Governance

Nov 8, 2025

•

5 min read

Weekly Signal: 32 | Tiny Implants, Big Governance

Miniaturized BCIs & Global Neuro-Ethics

Ricardo Albornoz
Ricardo Albornoz

Neurotechnology

+4

Weekly Signal: 30 | Vision Restored, Minds Regulated: Neurotech’s Pivotal Week

Oct 25, 2025

•

6 min read

Weekly Signal: 30 | Vision Restored, Minds Regulated: Neurotech’s Pivotal Week

Clinical Breakthroughs & Global Policy Shifts

Ricardo Albornoz
Ricardo Albornoz
Load more
The NeuroCircuit

The NeuroCircuit

The weekly briefing on neurotech for people building the future of the brain.


FAQs

NeuroCircuit

HackTheNeuron

© 2026 The NeuroCircuit.
Report abusePrivacy policyTerms of use
beehiivPowered by beehiiv